» Articles » PMID: 33968138

Identification of a Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Melanocytes for Investigating Pathogenesis of Vitiligo

Overview
Journal Front Genet
Date 2021 May 10
PMID 33968138
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

CircRNAs have been reported to play essential roles in regulating immunity and inflammation, which may be an important regulatory factor in the development of vitiligo. However, the expression profile of circRNAs and their potential biological functions in vitiligo have not been reported so far. In our study we found there are 64 dysregulated circRNAs and 14 dysregulated miRNAs in the patients with vitiligo. Through the correlation analysis, we obtained 12 dysregulated circRNAs and 5 dysregulated miRNAs, forming 48 relationships in the circRNA-miRNA-mRNA regulatory network. Gene Ontology analysis indicated dysregulated circRNAs in vitiligo is closely related to the disorder of the metabolic pathway. The KEGG pathway of dysregulation of circRNAs mainly enriched in the biological processes such as ubiquitin mediated proteolysis, endocytosis and RNA degradation, and in Jak-STAT signaling pathway. Therefore, we found the circRNA-miRNA-mRNA regulatory network are involved in the regulation of numerous melanocyte functions, and these dysregulated circRNAs may closely related to the melanocyte metabolism. Our study provides a theoretical basis for studying the vitiligo pathogenesis from the perspective of circRNA-miRNA-mRNA network.

Citing Articles

A comprehensive outline of the role of non-coding RNAs in vitiligo.

Feghahati F, Ghafouri-Fard S Biochem Biophys Rep. 2025; 41:101916.

PMID: 39881955 PMC: 11774809. DOI: 10.1016/j.bbrep.2025.101916.


Dietary Interventions, Supplements, and Plant-Derived Compounds for Adjunct Vitiligo Management: A Review of the Literature.

Diaz M, Tran J, Rose D, Wei A, Lakshmipathy D, Lipner S Nutrients. 2025; 17(2).

PMID: 39861486 PMC: 11767946. DOI: 10.3390/nu17020357.


An Overview of the Biological Complexity of Vitiligo.

Matarrese P, Puglisi R, Mattia G, Samela T, Abeni D, Malorni W Oxid Med Cell Longev. 2024; 2024:3193670.

PMID: 39735711 PMC: 11671640. DOI: 10.1155/omcl/3193670.


Post-translational modification in the pathogenesis of vitiligo.

Lu L, He H, Feng J, Hu Z, Zhang S, Yang L Immunol Res. 2024; 72(6):1229-1237.

PMID: 39320694 PMC: 11618162. DOI: 10.1007/s12026-024-09545-x.


Advances in vitiligo: Update on therapeutic targets.

Feng Y, Lu Y Front Immunol. 2022; 13:986918.

PMID: 36119071 PMC: 9471423. DOI: 10.3389/fimmu.2022.986918.


References
1.
Langmead B, Trapnell C, Pop M, Salzberg S . Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009; 10(3):R25. PMC: 2690996. DOI: 10.1186/gb-2009-10-3-r25. View

2.
Montilla A, Gomez-Garcia F, Gomez-Arias P, Gay-Mimbrera J, Hernandez-Parada J, Isla-Tejera B . Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata. Dermatol Ther (Heidelb). 2019; 9(4):655-683. PMC: 6828894. DOI: 10.1007/s13555-019-00329-y. View

3.
Delmas V, Larue L . Molecular and cellular basis of depigmentation in vitiligo patients. Exp Dermatol. 2018; 28(6):662-666. DOI: 10.1111/exd.13858. View

4.
Malhotra N, Dytoc M . The pathogenesis of vitiligo. J Cutan Med Surg. 2013; 17(3):153-72. DOI: 10.2310/7750.2012.12005. View

5.
Atas H, Gonul M . Increased Risk of Metabolic Syndrome in Patients with Vitiligo. Balkan Med J. 2017; 34(3):219-225. PMC: 5450861. DOI: 10.4274/balkanmedj.2016.1005. View